| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |